Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has improved in some technical and logistical areas since COVID-19. Significant gaps in leadership, coordination, funding sustainability, public health infrastructure, surveillance, supply chains, and trust persist, leaving the country vulnerable.[1][2]
Experts, bipartisan commissions, the Government Accountability Office (GAO), and assessments consistently describe a pattern of “panic and neglect”: temporary surges in attention and funding during crises followed by backsliding. The US ranked highest on the Global Health Security Index pre-COVID (and remains highly ranked in later assessments), yet it experienced one of the highest per-capita death rates among peer nations, exposing mismatches between paper capabilities and real-world performance.[3][4]
Progress Made
These steps mean the US could likely detect and initially respond faster in some scenarios than in early 2020, with better PPE availability and platform technologies for vaccines/diagnostics.
Persistent and Emerging Gaps
Bottom Line and Outlook
The US has stronger tools in specific domains (stockpiles, some tech platforms, data systems) than before 2020 and can handle many localized or moderate threats better. However, for a high-impact novel pathogen with efficient human-to-human transmission—especially one exploiting gaps in early detection, equitable distribution, sustained public compliance, or multi-sector cascading effects—it is not adequately prepared. The Bipartisan Commission concludes the nation “remains dangerously vulnerable” and calls for immediate action across leadership, science/tech, preparedness, detection, and response.[11]
Preparedness is a continuous process requiring stable multi-year funding, clear authorities, regular exercises with after-action implementation, domestic industrial base resilience, restored public trust, and whole-of-society (not just federal) engagement. Without addressing the open recommendations, funding cliff risks, and coordination shortfalls, performance in a future crisis risks repeating or worsening COVID-era shortcomings. Ongoing monitoring of threats like H5N1, investments in universal vaccines/diagnostics, and reauthorization/strengthening of key laws (e.g., PAHPA) are critical near-term steps. Assessments evolve with administrations and events, so current capabilities should be tracked via GAO, CDC/ASPR updates, and independent reviews.
Citations (18)
- https://www.gao.gov/products/gao-24-107175
Backs: “Significant gaps in leadership, coordination, funding sustainability, public health infrastructure, surveillance, supply chains, and trust persist, leaving the country vulnerable.”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant gaps in leadership, coordination, funding sustainability, public health infrastructure, surveillance, supply chains, and trust persist, leaving the country vulnerable.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “The US ranked highest on the Global Health Security Index pre-COVID (and remains highly ranked in later assessments), yet it experienced one of the highest per-capita death rates among peer nations, exposing mismatches between paper capabilities and real-world performance.”
- https://ghsindex.org/country/united-states/
Backs: “The US ranked highest on the Global Health Security Index pre-COVID (and remains highly ranked in later assessments), yet it experienced one of the highest per-capita death rates among peer nations, exposing mismatches between paper capabilities and real-world performance.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “BARDA and related efforts advanced medical countermeasures, including mRNA platforms adaptable to new threats, and achieved multiple FDA approvals.”
- https://www.aspr.gov/readiness-response/medical-countermeasures-biodefense/sns/emergency-response/response-history
Backs: “BARDA and related efforts advanced medical countermeasures, including mRNA platforms adaptable to new threats, and achieved multiple FDA approvals.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Wastewater surveillance, syndromic systems, and lab partnerships improved. CDC created “warm base” lab capacity and forecasting tools.”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “Biden-era roadmaps emphasized equity, global health security investments (billions in GHS), vaccine manufacturing scale-up, and playbooks for future threats.”
- https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “Biden-era roadmaps emphasized equity, global health security investments (billions in GHS), vaccine manufacturing scale-up, and playbooks for future threats.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Healthcare system surge elements and cross-sector coordination improved in places.”
- https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_.pdf
Backs: “Recent reports indicate OPPR was largely emptied or minimally staffed after the 2025 transition, with cuts or freezes to related R&D programs.”
- https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “Recent reports indicate OPPR was largely emptied or minimally staffed after the 2025 transition, with cuts or freezes to related R&D programs.”
- https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic
Backs: “Recent reports indicate OPPR was largely emptied or minimally staffed after the 2025 transition, with cuts or freezes to related R&D programs.”
- https://www.gao.gov/products/gao-24-105891
Backs: “GAO notes temporary COVID infrastructure gains often proved fleeting.”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “GAO notes temporary COVID infrastructure gains often proved fleeting.”
- https://www.gao.gov/products/gao-25-106980
Backs: “Public trust in institutions and vaccines eroded, complicating compliance.”
- https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca
Backs: “Biological threats (natural, accidental, deliberate) are assessed as growing.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “After-action reviews and exercises often fail to drive lasting change.”